Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial

Overview of attention for article published in Journal of Clinical Oncology, June 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 5 news outlets
blogs: 1 blog
twitter: 57 X users

patent: 1 patent
guideline: 1 clinical guideline source

Readers on

mendeley: 130 Mendeley

So far, Altmetric has seen 64 X posts from 57 X users, with an upper bound of 310,860 followers.

@dgermain21 See https://t.co/Eke2XlH1CT by Stanford group (Dr. Frank/Miklos) Larger multicenter clinical trial is ongoing https://t.co/rmWhGxCULJ

@MediHumdani @AaronGoodman33 @Dr_R_Kurzrock Similar findings in Frank et al. I must admit though just focusing on the unique Ig sequence and getting a (+) or (-) result seems more straightforward. Any advantages to this platform? https://t.co/yTsm7x5aao

RT @SCTNB: Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymp…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 60 additional X posts.